Department of Clinical Laboratory, The Second Affiliated Hospital of Zhengzhou University, #2 Jingba Road, Zhengzhou, 450014, China.
Intensive Care Medicine, Sanbo Brain Hospital, Capital Medical University, Beijing, 100093, China.
Clin Epigenetics. 2024 Nov 19;16(1):162. doi: 10.1186/s13148-024-01773-0.
In recent years, epigenetic modifications have been strongly linked to tumor development, with histone modifications representing a key epigenetic mechanism. In addition, non-coding RNAs (ncRNAs) play a critical role in regulating cancer-related pathways. The abnormal interaction between histone modifications and ncRNAs, both pivotal epigenetic regulators, has been widely observed across various cancer types. Here, we systematically explore the molecular mechanisms through which histone modifications and ncRNAs contribute in the pathogenesis of digestive system cancers, and aberrant ncRNA-mediated histone modifications manipulate various biological behaviors of tumor cells including proliferation, migration, angiogenesis, etc. In addition, we provide new insights into diagnostic, prognostic markers, therapeutic targets and chemoradiation resistance for digestive system cancers from the epigenetic perspective.
近年来,表观遗传修饰与肿瘤的发生发展密切相关,其中组蛋白修饰是重要的表观遗传机制之一。此外,非编码 RNA(ncRNA)在调控癌症相关通路中发挥着关键作用。组蛋白修饰和 ncRNA 这两种关键的表观遗传调控因子之间的异常相互作用在多种癌症类型中广泛存在。在这里,我们系统地探讨了组蛋白修饰和 ncRNA 在消化系统癌症发病机制中的作用机制,以及异常的 ncRNA 介导的组蛋白修饰如何调控肿瘤细胞的各种生物学行为,包括增殖、迁移、血管生成等。此外,我们从表观遗传学的角度为消化系统癌症提供了新的诊断、预后标志物、治疗靶点和放化疗耐药性的见解。